Timothy Shaw - 27 Apr 2023 Form 4 Insider Report for MARIMED INC. (MRMD)

Role: Chief Operating Officer
Signature: /s/ Timothy Shaw
Issuer symbol: MRMD
Transactions as of: 27 Apr 2023
Transactions value $: -$14,481
Form type: 4
Filing time: 01 May 2023, 20:16:35 UTC
Previous filing: 14 Mar 2023
Next filing: 06 Sep 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRMD	Common stock	Options Exercise		+111,111	+1.3%		8,410,619	27 Apr 2023	Direct	F1
transaction	MRMD	Common stock	Sale	-$14,480	-39,371	-0.47%	$0.3678	8,371,248	28 Apr 2023	Direct	F2
holding	MRMD	Common stock						2,000,000	27 Apr 2023	By the Shaw Family Trust	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRMD	Restricted Stock Units (RSU)	Options Exercise	$0	-111,111	-17%	$0	555,556	27 Apr 2023	Common Stock, par value $.001 per share	111,111		Direct	F1, F4
holding	MRMD	Restricted Stock Units (RSU)						130,000	27 Apr 2023	Common Stock, par value $.001 per share	130,000		Direct	F1, F5
holding	MRMD	Option to buy common stock						1,250,000	27 Apr 2023	Common Stock, par value $.001 per share	1,250,000	$0.898	Direct	F6
holding	MRMD	Option to buy common stock						1,250,000	27 Apr 2023	Common Stock, par value $.001 per share	1,250,000	$0.88	Direct	F6
holding	MRMD	Option to buy common stock						50,000	27 Apr 2023	Common Stock, par value $.001 per share	50,000	$0.3	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	RSUs convert to common stock on a one-for-one basis.
F2	Reflects common stock sold pursuant to a rule 10b5-1 instruction letter previously adopted by the Reporting Person to satisfy tax withholding obligations in connection with RSUs.
F3	The reporting person's spouse is the trustee of the trust and the shares held in the trust are for the benefit of the reporting person's children. The trust is an irrevocable trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F4	The RSUs vest over a three year period in equal one-sixth installments every six months following the October 27, 2022 grant date, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
F5	The RSUs vest over a three year period of which 43,333 RSUs will vest on March 7, 2024 and thereafter, 21,667 RSUs will vest every succeeding six (6) months through March 7, 2025, on each of September 7 and March 7, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
F6	Immediately